​

Vicarious Surgical Stock (NYSE:RBOT)

ForecastOwnershipFinancialsChartTranscripts
Vicarious Surgical by TradingView

Previous Close

$0.45

52W Range

$0.27 - $13.75

50D Avg

$0.68

200D Avg

$2.75

Market Cap

$3.11M

Avg Vol (3M)

$32.75K

Beta

1.77

Div Yield

-

RBOT Company Profile

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

123

IPO Date

Sep 04, 2020

Website

RBOT Performance

RBOT Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-50.03M$-66.56M$-80.67M
Net Income$-50.18M$-63.22M$-71.07M
EBITDA$-50.03M$-61.12M$-69.19M
Basic EPS$-8.19$-10.72$-14.70
Diluted EPS$-8.19$-10.72$-14.60

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q3 25Nov 12, 25 | 4:30 PM
Q2 25Aug 12, 25 | 4:30 PM
Q1 25May 12, 25 | 4:30 PM

Peer Comparison

TickerCompany
INTSIntensity Therapeutics, Inc.
HYPDHyperion DeFi, Inc.
PIIIP3 Health Partners Inc.
QTTBQ32 Bio Inc.
MODDModular Medical, Inc.
BOLDBoundless Bio, Inc.
NXLNexalin Technology, Inc.
ITRMIterum Therapeutics plc
PSTVPlus Therapeutics, Inc.